iBio, Inc. (IBIO): Revenue
$100.0K
Year ended 2026-06-30
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $100.0K | -75.0% | 2026-08-28, From 2025-07-01 |
| 2025-06-30 | $400.0K | +77.8% | 2026-08-28, From 2024-07-01 |
| 2024-06-30 | $225.0K | n/a | 2025-09-05, From 2023-07-01 |
| 2023-06-30 | $0 | -100.0% | 2024-09-24, From 2022-07-01 |
| 2022-06-30 | $1.88M | n/c | 2023-09-27, From 2021-07-01 |
| 2021-06-30 | $2.37M | +44.7% | 2022-10-11, From 2020-07-01 |
| 2020-06-30 | $1.64M | -18.8% | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | $2.02M | +354.5% | 2020-10-13, From 2018-07-01 |
| 2018-06-30 | $444.0K | +12.7% | 2019-08-26, From 2017-07-01 |
| 2017-06-30 | $394.0K | -58.4% | 2018-09-18, From 2016-07-01 |
| 2016-06-30 | $948.0K | -48.8% | 2017-09-15, From 2015-07-01 |
| 2015-06-30 | $1.85M | +802.9% | 2016-10-13, From 2014-07-01 |
| 2014-06-30 | $205.0K | -79.6% | 2015-10-13, From 2013-07-01 |
| 2013-06-30 | $1.01M | -21.1% | 2014-09-29, From 2012-07-01 |
| 2012-06-30 | $1.28M | +145.5% | 2013-10-04, From 2011-07-01 |
| 2011-06-30 | $520.1K | n/a | 2012-10-15, From 2010-07-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| iBio, Inc. (IBIO) | 2026-06-30 | $100.0K | -75.0% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $90.0K | n/a |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $116.7K | n/a |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $130.0K | +132.1% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $72.1K | 0.0% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $65.3K | -70.0% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $64.0K | -99.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $59.0K | -86.6% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $170.0K | -83.0% |
Compare IBIO, ATNM, BFRG, SER side by side · Screen every company in Pharmaceutical Preparations ↗